Infrastructure Scalability in Healthcare IT

Scaling in HealthTech is fundamentally different from traditional tech. The path is slower, costlier, and filled with unique, compounding challenges. These barriers span technical, financial, regulatory, and cultural domains-and they rarely get the honest scrutiny they deserve. 1. IT Infrastructure Complexity Building scalable infrastructure in HealthTech is no small feat. Cybersecurity is non-negotiable due to the sensitive nature of patient data, requiring advanced protections and strict compliance with privacy laws. But beyond security, the real killer is interoperability. New solutions must plug into an ecosystem of legacy EHRs, fragmented platforms, and inconsistent data standards. Data management becomes a second challenge-volume, quality, integrity, and compliance must all be handled at scale. 2. Funding Gaps and Long Timelines to Profitability Investors often underestimate the runway HealthTech startups need. Clinical validation, regulatory approval, procurement processes, and evidence generation all extend the time to market. Compared to faster-moving SaaS or fintech models, HealthTech has higher upfront R&D costs and far longer sales cycles. Even post-launch, monetisation is slow, especially in public health systems like the NHS. 3. Adoption Friction and Resistance Clinicians are overwhelmed-by admin, by tools, by time pressures. New tech, even if useful, can feel like "just another login." Adoption requires more than good UX or feature sets. It demands deep integration into existing clinical workflows and clear, demonstrable time savings. Without that, even validated solutions can sit on the shelf. 4. Fragmented and Inaccessible Data Health data is the foundation of innovation-yet most startups can't access it. Regulatory constraints, patient privacy, and governance processes all make data acquisition a major blocker. Even when access is granted, data quality and format vary widely between providers, making it difficult to build robust, generalisable models-especially for AI-driven solutions. 5. Technical Debt Limits Future Scale Early-stage choices come back to haunt many HealthTech teams. MVPs built quickly to secure funding often lack the architecture to scale or meet evolving regulatory needs. Legacy systems, rigid data models, and brittle codebases create technical debt that slows down progress and makes integrating modern capabilities-like cloud, FHIR, or AI-an uphill battle. 6. Regulatory Burden and Shifting Standards The regulatory landscape is not only complex but constantly moving. Certification from bodies like MHRA, compliance with NHS DTAC/DCB standards, and alignment with GDPR are table stakes. But these aren't "set once and forget." Requirements evolve, and staying compliant while moving fast is a strategic balancing act. For many startups, the lack of internal regulatory expertise becomes a bottleneck to scaling confidently. Most playbooks don't apply here IMO.

Most healthcare AI doesn't stall because models underperform. It stalls because infrastructure is fragmented. We are no longer constrained by algorithmic creativity. We are constrained by data silos, privacy governance, interoperability gaps, compute access, and the operational friction of translating retrospective research into prospective clinical impact. This brief examines this structural bottleneck through the Mayo Clinic Platform. The authors focus on something foundational: building an AI-ready ecosystem designed to accelerate real-world clinical research at scale. The platform provides a secure, cloud-based research environment built on de-identified, standardized EHR data from more than 15 million patients. Key capabilities include: ⭐ OMOP-aligned data models for interoperability ⭐ Structured and unstructured data ⭐ Cohort-building and schema exploration tools ⭐ Integrated workspaces with scalable CPU/GPU infrastructure ⭐ Both no-code and advanced coding environments Unlike traditional institutional repositories, Mayo Clinic Platform enables access for external researchers, supports federated multi-institutional data contributions, and embeds analytics within a privacy-preserving architecture. The paper highlights four applied studies conducted within MCP: 1️⃣ RCT emulation for heart failure drug efficacy using observational data 2️⃣ Validation of antihypertensive medications and reduced dementia risk 3️⃣ Deep learning prediction of mild cognitive impairment progression to Alzheimer’s disease 4️⃣ Neural network prediction of major adverse cardiovascular events after liver transplantation Extracting a cohort of ~15,000 patients took approximately one week. Training and running a deep learning model required roughly 10 minutes on moderate compute resources. When infrastructure friction is minimized, research velocity changes materially. Competitive advantage in healthcare AI is increasingly defined by: 💫 Data harmonization at scale 💫 Federated, privacy-preserving architectures 💫 Reproducible research pipelines 💫 Integrated compute environments 💫 Lower barriers for clinician engagement The authors also point toward multimodal expansion (notes, imaging, genomics), large-scale cross-institutional validation, and “Clinical Trials Beyond Walls” models that broaden participation and diversify real-world evidence. For those shaping AI strategy in health systems, pharma, or digital health, this paper offers a concrete example of production-grade, AI-ready infrastructure. The future of healthcare AI will not be won by isolated models. It will be won by platforms that integrate data, governance, compute, and workflow into a coherent operating system for translational impact. John Halamka, M.D., M.S. and team, great work! #HealthcareAI #HealthSystems #RealWorldEvidence #ClinicalResearch #DigitalHealth #TranslationalMedicine #PrecisionMedicine #HealthData #AIInfrastructure #MedicalInnovation

As part of our conversation at the World Economic Forum Strategic Intelligence Outlook, one message became very clear: Healthcare is entering its AI-native era but without the right infrastructure, none of its potential becomes real. Today, every country, provider, and life sciences organisation is asking the same questions: • How do we deploy AI safely? • How do we scale digital health beyond pilots? • How do we turn fragmented data into real clinical and research impact? This is exactly the space where Huma is redefining what’s possible. 🚀 What Huma enables Huma powers digital and AI-driven healthcare at national scale across 70+ countries, 4,500+ hospitals, and nearly 100 million patients. Our Huma Cloud Platform (HCP v5) gives organisations something the industry has been missing: ➡️ A single, regulated platform to launch any digital health application — 10x faster ➡️ AI-ready infrastructure that connects devices, EHRs, imaging, wearables, and real-world outcomes ➡️ End-to-end deployment from patient app → clinical workflow → research-grade data ➡️ Global regulatory clearance (FDA, EU MDR, Saudi FDA, India CDSCO) built into the core Instead of building from scratch, teams can now configure and launch: • Digital disease pathways • Remote monitoring programs • Clinical research platforms • Screening & diagnostic workflows • Predictive AI tools wrapped in regulated apps …and do so at speed, with full compliance and enterprise-grade reliability. 🔍 Why this matters now The discussions at WEF highlighted a major shift: Healthcare is no longer about individual solutions, it’s about ecosystems and trusted platforms. Clients want outcomes, not complexity. They want one foundation that lets them innovate repeatedly, globally, and safely. That is why governments, global pharma, and providers choose Huma: we turn strategy into live deployment, and deployment into measurable clinical, operational, and research value. 🌍 Looking ahead The next wave of healthcare innovation will come from organisations who can combine: • AI + regulated infrastructure + real-world data • Speed + safety • Innovation + trust This is the intersection where Huma operates and where we are seeing some of the most transformative work emerge. If your organisation is exploring how to scale AI-native digital health, I’d be delighted to connect and exchange ideas.

The AI infrastructure gap is healthcare's most expensive invisible problem. Health systems are spending millions on AI solutions while missing the foundation that makes any of them work at scale. When we started building AI solutions at Duke Institute for Health Innovation, everyone focused on the models—sepsis prediction, deterioration detection, clinical decision support. Two years and 60+ deployments later, we can confidently share: infrastructure underlies and enables strategy. Real AI infrastructure does three things most health systems don't have: 1. Curates and normalizes messy healthcare data  Ever tried normalizing serum creatinine values reported in both mg/dL and mg/mL? We have. It's critical to making models actually work—and most vendors expect you to figure it out yourself. 2. Provides a standardized runtime environment So you can evaluate solutions from different developers without rebuilding your tech stack each time. Want to compare which model works best with your patient population? Evaluate a model on retrospective data, a silent trial, and full-scale clinical integration? You need this. 3. Enables enterprise-wide monitoring Real performance data from your environment, measured consistently across all models. Without these capabilities, you're not building an AI strategy. You're collecting pilots that won't scale easily. In our latest piece, we break down the importance of infrastructure, and how we're addressing this at Vega Health. The Vega Health Platform runs in a health system's local environment, behind their firewall. The system keeps control of your data. Vega Health gives you the foundation to evaluate, integrate, and monitor any AI solution. Because infrastructure is necessary to maintain your independence and properly integrate AI to advance your organization's strategy. This article is part 1 of 4 on scaling healthcare AI. More coming on marketplace navigation, implementation, and commercialization. #HealthcareInnovation #AIInHealthcare #HealthTech #ClinicalAI

Most healthcare organizations are no longer asking whether to adopt AI. They are asking a much harder question: How do we move from AI pilots to reliable production systems that actually improve care and operations? Across healthcare, we see the same pattern: AI initiatives start strong but stall when they hit real-world complexity. Data readiness gaps. Legacy infrastructure. Model governance challenges. Operational AI at scale. This is exactly the problem Klika Tech’s Klika new VELOCITY™ program is designed to solve. VELOCITY is a value-engineered lifecycle for optimized corporate AI that moves organizations from strategy to production through a structured approach to data readiness, cloud modernization, model implementation, and AI Ops stabilization. Instead of isolated AI experiments, the program focuses on building production foundations: • Aligning AI investments with real business priorities and measurable outcomes • Establishing modern data and cloud infrastructure required for scalable AI • Delivering production-ready AI use cases • Stabilizing AI systems through operational governance and monitoring • Managing AI operations at enterprise scale For healthcare leaders, this matters a lot. Modern AI systems depend on secure cloud architectures, mature data pipelines, and disciplined AI Ops practices to meet regulatory, reliability, and safety expectations. Klika Tech brings deep expertise across cloud-native platforms, AI/ML, IoT, and data engineering, helping organizations build scalable digital solutions across healthcare and other industries. The next phase of AI transformation will be about operational AI systems that deliver measurable outcomes. Programs like VELOCITY reflect an important shift in the industry: AI must be engineered like enterprise infrastructure, not treated like experimentation. For healthcare leaders navigating modernization, the real question is no longer “What model should we use?” It is: “Do we have the architecture, governance, and AI Ops discipline to run AI at scale?” Learn more about the VELOCITY program here: https://lnkd.in/gP_-uH6R Curious how others are approaching this. Where do you see the biggest bottleneck in moving AI from pilot to production in healthcare? #AI #HealthcareAI #AIOps #CloudTransformation #EnterpriseAI #AWS #DigitalHealth